Showing posts with label Maternal HIV. Show all posts
Showing posts with label Maternal HIV. Show all posts

Monday, April 4, 2016

Predictors of Disclosure of Maternal HIV Status by Caregivers to their Children in an Inner-City Community in the United States

Disclosure of HIV status to children is a challenge parents living with HIV face. To evaluate predictors of maternal HIV disclosure in a low-income clinic in the U.S. that serves an African American, Hispanic and immigrant population with high HIV prevalence, 172 caregivers with 608 children completed a standardized survey. 

Caregivers were 93% female, 84% biological mothers, and 34% foreign born. Sixty-two (36 %) caregivers had at least one disclosed child, 42 of whom also had other nondisclosed children. Of all children, 581 (96%) were uninfected and 181 (30 %) were disclosed. Caregiver's U.S. birth, child's age, and increased HIV-stigma perception by caregiver predicted disclosure. Children were more often disclosed if their caregiver was born in the U.S. or reported higher HIV-related stigma. 

These findings suggest that complex family context may complicate disclosure, particularly among immigrants.

Purchase full article at:   http://goo.gl/eh7v2d

  • 1Columbia University, Mailman School of Public Health, Environmental Health Department, New York, NY, USA. rozanabdul@gmail.com.
  • 2Bronx-Lebanon Hospital Center, Department of Pediatrics, Bronx, NY, USA.
  • 3Columbia University, Mailman School of Public Health, Department of Epidemiology, New York, NY, USA. 
  •  2016 Mar 24. 



Thursday, October 29, 2015

Associations between Gestational Anthropometry, Maternal HIV & Fetal & Early Infancy Growth in a Prospective Rural/Semi-Rural Tanzanian Cohort, 2012-13

Healthcare access and resources differ considerably between urban and rural settings making cross-setting generalizations difficult. In resource-restricted rural/semi-rural environments, identification of feasible screening tools is a priority. The objective of this study was to evaluate gestational anthropometry in relation to birth and infant growth in a rural/semi-rural Tanzanian prospective cohort of mothers and their infants.

Mothers (n = 114: 44 HIV-positive) attending antenatal clinic visits were recruited in their second or third trimester between March and November, 2012, and followed with their infants through 6-months post-partum. Demographic, clinical, and infant feeding data were obtained using questionnaires administered by a Swahili-speaking research nurse on demographic, socioeconomic, clinical, and infant feeding practices. Second or third trimester anthropometry (mid-upper arm circumference [MUAC], triceps skinfold thickness, weight, height), pregnancy outcomes, birth (weight, length, head circumference) and infant anthropometry (weight-for-age z-score [WAZ], length-for-age z-score [LAZ]) were obtained. Linear regression and mixed effect modeling were used to evaluate gestational factors in relation to pregnancy and infant outcomes.

Gestational MUAC and maternal HIV status (HIV-positive mothers = 39 %) were associated with infant WAZ and LAZ from birth to 6-months in multivariate models, even after adjustment for infant feeding practices. The lowest gestational MUAC tertile was associated with lower WAZ throughout early infancy, as well as lower LAZ at 3 and 6-months. In linear mixed effects models through 6-months, each 1 cm increase in gestational MUAC was associated with a 0.11 increase in both WAZ (P < 0.001) and LAZ (P = 0.001). Infant HIV-exposure was negatively associated with WAZ (β = -0.65, P < 0.001) and LAZ (β = -0.49, P < 0.012) from birth to 6-months.

Lower gestational MUAC, evaluated using only a tape measure and minimal training that is feasible in non-urban clinic and community settings, was associated with lower infant anthropometric measurements. In this rural and semi-rural setting, HIV-exposure was associated with poorer anthropometry through 6-months despite maternal antiretroviral access. Routine assessment of MUAC has the potential to identify at-risk women in need of additional health interventions designed to optimize pregnancy outcomes and infant growth. Further research is needed to establish gestational MUAC reference ranges and to define interventions that successfully improve MUAC during pregnancy.

Below:  Mean weight-for-age and length-for-age z-scores, stratified on infant HIV-exposure or gestational mid-upper arm circumference. Models stratified on infant HIV-exposure (a and b, where “HIV-U” = infant HIV-unexposed, “HIV-E” = infant HIV-exposed) or gestational mid-upper arm circumference (c and d, where “Low MUAC” = lowest gestational mid-upper arm circumference tertile, “High MUAC” = middle and highest tertiles combined). Dotted lines depict z-scores of zero. All models adjusted for gestational age; post hoc pairwise comparisons used to generate predicted marginal means and 95 % CI at each time point. *P < 0.01, **P < 0.001



Below:  Mean weight-for-age and length-for-age z-scores, stratified on infant HIV-exposure plus gestational mid-upper arm circumference. Models stratified on infant HIV-exposure (Fig. 2a and b, where “HIV-U” = infant HIV-unexposed, “HIV-E” = infant HIV-exposed) or gestational mid-upper arm circumference (Fig. 2c and d, where “Low MUAC” = lowest gestational mid-upper arm circumference tertile, “High MUAC” = middle and highest tertiles combined). Dotted lines depict z-scores of zero. All models adjusted for gestational age; post hoc pairwise comparisons were used to generate predicted marginal means and 95 % CI at each time point and the significance threshold after Bonferroni correction; significance was P < 0.01. Significant differences were observed for the following weight-for-age z-scores: -HIV-U/High MUAC vs. HIV-U/Low MUAC at months 2, 3, and 6; -HIV-U/High MUAC vs. HIV-E/High MUAC at months 2 and 3; -HIV-U/High MUAC vs. HIV-E/Low MUAC at each time points. Significant differences were observed for the following length-for-age z-scores: -HIV-U/High MUAC vs. HIV-U/Low MUAC at month 6; -HIV-U/High MUAC vs. HIV-E/Low MUAC at months 3 and 6



Full article at: http://goo.gl/DFOaDt

By: Amanda L. Wilkinson1, Sarah H. Pedersen1, Mark Urassa2, Denna Michael2, Jim Todd3,Safari Kinung’hi2, John Changalucha2 and Joann M. McDermid14*
1Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA
2National Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania
3Department of Population Health, London School of Hygiene & Tropical Medicine, London, UK
4Present affiliation: Division of Infectious Diseases & International Health, Department of Medicine, School of Medicine, University of Virginia, Charlottesville, VA, USA